Core Viewpoint - The joint release of the "Implementation Opinions on Promoting the Innovative Development of Brain-Machine Interface Industry" aims to accelerate the research and development of implantable devices and enhance the application of brain-machine interfaces across various sectors, including industrial manufacturing and healthcare [1][2]. Group 1: Development Goals - By 2027, breakthroughs in key technologies related to brain-machine interfaces are expected, establishing an advanced technical, industrial, and standard system [2]. - The industry is projected to grow significantly, with the creation of 2 to 3 industrial development clusters and the emergence of new scenarios, models, and business formats [2]. - By 2030, the innovation capability of the brain-machine interface industry is anticipated to be significantly enhanced, fostering 2 to 3 globally influential leading enterprises and a number of specialized small and medium-sized enterprises [2]. Group 2: Product Development - The focus is on accelerating the R&D of implantable devices, including high-density neural recording sensors and ultra-low power implantable chips, to improve control precision and response speed [2][3]. - Non-invasive devices are also being promoted, with innovations in product forms such as adhesive, ear, and head-mounted devices, aiming for lightweight, high-speed, and low-power characteristics [3]. - Development of auxiliary devices is encouraged, integrating brain signals with other physiological signals to enhance interaction control and perception assessment accuracy [3]. Group 3: Policy Support and Market Impact - The opinions emphasize strengthening technological breakthroughs and application demonstrations, with increased investment from national funds to support the industry [4]. - Specific pricing for invasive brain-machine interface procedures has been established, with insertion fees set at 6,580 yuan and removal fees at 3,150 yuan, which is expected to stimulate market growth [4]. - The successful initiation of clinical trials for implantable brain-machine interfaces in China marks a significant milestone, positioning the country as the second globally to enter this phase after the United States [4]. Group 4: Industry Collaboration - The development of brain science is highlighted as a typical case of interdisciplinary collaboration, requiring cooperation among technology developers, clinical institutions, capital, and government [5]. - Startups in this field are advised to balance short-term survival needs with long-term innovation goals to avoid compromising core technology development due to market pressures [5].
脑机接口 大利好！
Shang Hai Zheng Quan Bao·2025-08-07 14:33